Autism is a spectrum of disorders characterized by marked abnormalities in communication and social interactions. Two common findings among children with this disorder are diminished oxygenation in specific areas of the brain and a chronic immunologically mediated inflammatory condition in the gut.
Current investigative therapies for autism attempt to reverse these abnormalities through administration of antibiotics, anti‐inflammatory agents, and hyperbaric oxygen. Unfortunately, none of these approaches address the root causes of oxygen deprivation and intestinal inflammation.
Umbilical cord tissue-derived mesenchymal stem cells may help treat autism. The rationale behind stem cell therapy for autism is that autism, and its degree of severity, has been significantly correlated with inflammatory and neuro-inflammatory cytokines including macrophage-derived chemokine (MDC) and thymus and activation-regulated chemokine (TARC). Intravenous administration of umbilical cord MSCs has been shown in multiple clinical trials to decrease inflammation. Decreasing inflammation in the autistic patient may alleviate symptoms of autism.
Allogeneic stem cells can be administered multiple times over the course of days in uniform dosages that contain high cell counts. Concentrated umbilical cord stem cells are administered intravenously.
To learn more about Regenerative Cell Institute’s stem cell treatments for Autism, or to schedule a consultation with Dr. Santos, please contact us. Our stem cell treatment centers are in Las Vegas, Nevada, and Mason City, Iowa.